Head, Biopharmaceutics
Dr. Reddy’s Laboratories Ltd, United States
Mr. Sivacharan Kollipara is currently working as Head, Biopharmaceutics department in the Global Clinical Management group, IPDO at Dr. Reddy’s Laboratories Limited (DRL), Hyderabad. He is responsible for biopharmaceutics evaluation, bioequivalence risk assessment, and bioequivalence prediction for conventional as well as complex generic products at DRL. He is also involved in PK modeling and simulations activities supporting generic drug development of various immediate release, modified release, and complex products at DRL and involved in utilizing novel PBPK and PBBM modeling approaches for regulatory justifications for various markets. Prior to joining DRL, Mr. Kollipara was Principal Scientist (Global Pharmaceutical Development) at Novartis Healthcare Pvt Ltd., Hyderabad. Previously he also has been associated with Ranbaxy Research Laboratories, Gurgaon (Metabolism and Pharmacokinetics). He obtained Masters in Pharmaceutical Sciences from BITS, Pilani, Rajasthan, India and currently pursuing Ph.D. Mr. Kollipara is also Chair Person, Scientific Planning Committee for SOPHAS (Society of Pharmacometrics & Health Analytics), India. Overall Mr. Kollipara has an experience of 18 years in the field of drug discovery, development and generic product development, bioanalytical method development and validation, PK data modelling and simulations. He has authored/co-authored more than 40 peer-reviewed publications and is scientific reviewer for many peer-reviewed journals. His research interests include PBPK/PBBM modeling, virtual bioequivalence simulations, IVIVC/R, drug-drug interactions, dissolution/bioequivalence safe space, bio-predictive dissolution methodologies, biowaivers, novel statistical tools for dissolution similarity analysis and food effect evaluations.
Disclosure information not submitted.
Tuesday, October 21, 2025
1:45 PM - 3:15 PM MDT
Tuesday, October 21, 2025
2:45 PM - 3:05 PM MDT
Tuesday, October 21, 2025
3:05 PM - 3:15 PM MDT